Pfizer has lowered its revenue forecast for the year 2025 to $62 billion. This drop is due to the company’s efforts to change its business strategy, which aims to remake its operations. Analysts still support Pfizer’s plan, but its stock price took a hit on Tuesday with a 3.7% decline.
Source: https://www.marketwatch.com/story/heres-why-pfizer-is-revising-its-revenue-forecasts-c6ed3e12